{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:10:24Z","timestamp":1781197824127,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jep.2023.116393","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T15:47:14Z","timestamp":1680104834000},"page":"116393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Yuanzhi Powder inhibits tau pathology in SAMP8 mice: Mechanism research of a traditional Chinese formula against Alzheimer's disease"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-6286","authenticated-orcid":false,"given":"Bin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2023.116393_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.jep.2023.116393_bib2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.exger.2005.05.007","article-title":"The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease","volume":"40","author":"Butterfield","year":"2005","journal-title":"Exp. Gerontol."},{"issue":"7","key":"10.1016\/j.jep.2023.116393_bib3","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/acs.jafc.9b07022","article-title":"Specific degradation of endogenous tau protein and inhibition of tau fibrillation by tanshinone IIA through the ubiquitin-proteasome pathway","volume":"68","author":"Cai","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"6 Pt 2","key":"10.1016\/j.jep.2023.116393_bib4","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","article-title":"Tau protein function in living cells","volume":"103","author":"Drubin","year":"1986","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.jep.2023.116393_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.jep.2023.116393_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/brain\/awz019","article-title":"Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers","volume":"142","author":"Gordon","year":"2019","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jep.2023.116393_bib7","first-page":"2144","article-title":"Effects of Yuanzhi powder on learning and memory ability and oxidative stress level of D-galactose induced aging mice","volume":"37","author":"Guo","year":"2019","journal-title":"CHINESE ARCHIVES OF TRADITIONAL CHINESE MEDICINE"},{"issue":"3","key":"10.1016\/j.jep.2023.116393_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"21","key":"10.1016\/j.jep.2023.116393_bib9","first-page":"8","article-title":"Effect of yuanzhisan on learning and memory abilities and food intake of AD rats based on ghrelin level of cerebrointestinal peptide","volume":"26","author":"Hao","year":"2020","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.jep.2023.116393_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.jep.2023.116393_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jep.2023.116393_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-2009-0960","article-title":"Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease","volume":"16","author":"Huang","year":"2009","journal-title":"J. Alzheimers. Dis."},{"issue":"12","key":"10.1016\/j.jep.2023.116393_bib13","first-page":"e661","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. The Lancet","volume":"5","author":"Jia","year":"2020","journal-title":"Publ. Health"},{"issue":"Pt 24","key":"10.1016\/j.jep.2023.116393_bib14","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.jep.2023.116393_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1369\/0022155415610792","article-title":"Optimization of single- and dual-color immunofluorescence protocols for formalin-fixed, paraffin-embedded archival tissues","volume":"64","author":"Kajimura","year":"2016","journal-title":"J. Histochem. Cytochem."},{"issue":"4","key":"10.1016\/j.jep.2023.116393_bib16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dem."},{"issue":"1","key":"10.1016\/j.jep.2023.116393_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jep.2023.116393_bib18","first-page":"733","article-title":"Effects of Yuanzhi san on ethology and cerebral acetylcholinesterase activity of memory disorder mouse model induced by scopolamine","volume":"34","author":"Li","year":"2017","journal-title":"J. Guangzhou Univ.Trad.Chin. Med."},{"issue":"2","key":"10.1016\/j.jep.2023.116393_bib19","first-page":"111","article-title":"Clinical study of modified Yuanzhi powder combined with aniracetam for amnestic mild cognitive impairment(orifices confused by phlegm- turbid)","volume":"48","author":"Li","year":"2021","journal-title":"LIAONING JOURNAL OF TRADITIONAL CHINESE MEDICINE"},{"issue":"4","key":"10.1016\/j.jep.2023.116393_bib20","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11918","article-title":"Yuanzhisan inhibits tau protein aggregation in an Abeta140induced Alzheimer's disease rat model via the ubiquitinproteasome system","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.jep.2023.116393_bib21","first-page":"2238","article-title":"Effect and mechanism of Yuanzhi powder on spatial cognitive impairment in R ats with Alzheimer's disease","volume":"43","author":"Li","year":"2020","journal-title":"J. Chin. Med. Mater."},{"issue":"5","key":"10.1016\/j.jep.2023.116393_bib22","first-page":"2929","article-title":"Mechanism of Yuanzhi Powder on improving the learning and memory ability of SAMP8 mice based on ubiquitin-proteasome system","volume":"37","author":"Li","year":"2022","journal-title":"CJTCMP"},{"issue":"7","key":"10.1016\/j.jep.2023.116393_bib23","first-page":"223","article-title":"Screening of core herbal combinations in anti-alzheimer prescriptions by using traditional Chinese medicine inheritance system","volume":"22","author":"Liu","year":"2016","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"5","key":"10.1016\/j.jep.2023.116393_bib24","first-page":"1150","article-title":"Study on the quality evaluation of Yuanzhi powder in different origins by HPLC fingerprint","volume":"34","author":"Liu","year":"2022","journal-title":"Chem. Res. Appl."},{"issue":"1","key":"10.1016\/j.jep.2023.116393_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.jep.2023.116393_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.jep.2023.116393_bib27","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1111\/bph.14593","article-title":"Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy","volume":"176","author":"Nalivaeva","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.jep.2023.116393_bib28","first-page":"2894","article-title":"Strategy of development and scientifi c research on chronic complexity diseases in traditional Chinese medicine","volume":"31","author":"Pang","year":"2016","journal-title":"CJTCMP"},{"issue":"1","key":"10.1016\/j.jep.2023.116393_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer's disease","volume":"77","author":"Perl","year":"2010","journal-title":"Mt. Sinai J. Med."},{"issue":"4","key":"10.1016\/j.jep.2023.116393_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/mol.118.114348","article-title":"Derivatives of piperazines as potential therapeutic agents for Alzheimer's disease","volume":"95","author":"Popugaeva","year":"2019","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.jep.2023.116393_bib31","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.febslet.2007.02.065","article-title":"Effects of tau phosphorylation on proteasome activity","volume":"581","author":"Ren","year":"2007","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.jep.2023.116393_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2021.11558","article-title":"Recently approved alzheimer drug raises questions that might never Be answered","volume":"326","author":"Rubin","year":"2021","journal-title":"JAMA"},{"issue":"10284","key":"10.1016\/j.jep.2023.116393_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jep.2023.116393_bib34","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","article-title":"Advanced Maillard reaction end products are associated with Alzheimer disease pathology","volume":"91","author":"Smith","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jep.2023.116393_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2023.116393_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-biochem-060410-150257","article-title":"Molecular architecture and assembly of the eukaryotic proteasome","volume":"82","author":"Tomko","year":"2013","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.jep.2023.116393_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-020-00678-3","article-title":"A phase II randomized trial of sodium oligomannate in Alzheimer's dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"issue":"5","key":"10.1016\/j.jep.2023.116393_bib38","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.jep.2023.116393_bib39","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41419-020-03270-7","article-title":"Delta-secretase triggers Alzheimer's disease pathologies in wild-type hAPP\/hMAPT double transgenic mice","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.jep.2023.116393_bib40","first-page":"167","article-title":"Yuanzhi powder regulates phosphorylation of tau protein through PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer's disease model rats","volume":"38","author":"Xie","year":"2020","journal-title":"CHINESE ARCHIVES OF TRADITIONAL CHINESE MEDICINE"},{"issue":"3","key":"10.1016\/j.jep.2023.116393_bib41","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1471-4159.2007.04603.x","article-title":"Inhibition of protein phosphatases induces transport deficits and axonopathy","volume":"102","author":"Yang","year":"2007","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jep.2023.116393_bib42","first-page":"281","article-title":"[Effect of electroacupuncture combined with Donepezil on learning-memory ability and expression of hippocampal beta-amyloid clearance-related genes in SAMP8 mice]","volume":"45","author":"Yang","year":"2020","journal-title":"Zhen Ci Yan Jiu"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123002611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123002611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:58:21Z","timestamp":1736402301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874123002611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":42,"alternative-id":["S0378874123002611"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2023.116393","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yuanzhi Powder inhibits tau pathology in SAMP8 mice: Mechanism research of a traditional Chinese formula against Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2023.116393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116393"}}